Crocetin: An agent derived from saffron for prevention and therapy for cancer

Current Pharmaceutical Biotechnology

Volumn 13, Issue 1, 2012, Pages 173-179

  Gutheil, William G ^a   Reed, Gregory ^b   Ray, Amitabha ^c   Anant, Shrikant ^d   Dhar, Animesh ^d,e  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cancer; Carotenoids; Chemoprevention; Crocetin; Saffron

Indexed keywords

AFLATOXIN B1; ALANINE AMINOTRANSFERASE; ANTINEOPLASTIC AGENT; ASPARTATE AMINOTRANSFERASE; CATALASE; CISPLATIN; CROCETIN; CROCIN; CYCLIN B1; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; HISTONE H1; PACLITAXEL; PROTEIN BAX; RNA POLYMERASE II; SUPEROXIDE DISMUTASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BREAST CANCER; CANCER INHIBITION; CANCER PREVENTION; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL VIABILITY; COLORECTAL CANCER; DNA ADDUCT; DNA REPLICATION; DRUG CYTOTOXICITY; DRUG STRUCTURE; EPIGENETICS; GENOTOXICITY; HELA CELL; HUMAN; INTERACTIONS WITH DNA; LIPID PEROXIDATION; LUNG CANCER; MYELOID LEUKEMIA; NONHUMAN; PANCREAS CANCER; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; REVIEW; SKIN TUMOR; UTERINE CERVIX CANCER;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAROTENOIDS; CROCUS; HUMANS; NEOPLASMS;

ANIMALIA; CROCUS SATIVUS;

EID: 84855851876     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920112798868566     Document Type: Review

References (66)

1. Jemal, A.; Siegel, A.; Xu, J.; Ward, E. Cancer statistics. CA Cancer J. Clin., 2010, 60, 277-300.
2. Lee, B.M.; Park, K.K. Beneficial and adverse effects of chemopreventive agents. Mutat. Res., 2003, 523, 265-278.
3. Nair, S.C.; Kurumboor, S.K.; Hasegawa, J.H. Saffron chemoprevention in biology and medicine: a review. Cancer Biother., 1995, 10, 257-264.
4. Aggarwal, B.B.; Shishodia, S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol., 2006, 71, 1397-1421.
5. Kunnumakkara, A.B.; Anand, P.; Harikumar, K.B.; Aggarwal, B.B. DNA Damage and Cancer Prevention by Polyphenols. In: Chemoprevention of Cancer and DNA damage by Dietary Factors; Knasmüller, S., Demarini, D. M., Johnson, I., Gerhauser, C., Eds.; Wiley-VCH: Weinheim, 2009; pp. 455-482.
6. Kim-Jun, H. Inhibitory effects of alpha and beta carotene on croton oil-induced or enzymatic lipid peroxidation and hydrogen peroxide production in mouse epidermis. Int. J. Biochem., 1993, 25, 911-915.
7. Colburn, N. A Comprehensive Survey; In: In carcinogenesis, Slaga, T. J. Ed.; Raven Press, New York, 1979, Vol. 5, pp. 35-36.
8. Tarantilis, P.A.; Morjani, H.; Pollissiou, M.; Manfeit, M. Inhibition of growth and induction of differentiation of promyelocytic leukemia (HL-60) by caratenoids from Crocus sativus L. Anticancer Res., 1994, 14, 1913-1918.
9. Greasey, W.A. Cancer: An Introduction. In: Unproven and Dietary Treatments for Cancer. Greasey, W. A., Ed.; Oxford University Press: New York, 1981; pp. 230-237.
10. Fields, A. L.; Soprano, D.R.; Soprano, K. J. Retenoids in biological control and cancer. J. Cell Biochem., 2007, 102, 886-898.
11. Brtko, J. Retinoids, rexinoids and their cognate nuclear receptors: character and their role in chemoprevention of selected malignant diseases. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc. Czech Repub., 2007, 151, 187-194.
12. Niles, R.M. Biomarker and animal models for assessment of retinoid efficacy in cancer chemoprevention. Acta. Pharmacol. Sin., 2007, 28, 1383-1391.
13. Mathews-Roth, M. Antitumor activity of beta-carotene, canthaxanthin and phytoene. Oncology, 1982, 39, 33-37.
14. Lippman, S. M.; Kessler, J. F.; Meyskens, F.L. Jr. Retinoids as preventive and therapeutic anticancer agents (Part I). Cancer Treat. Rep., 1987, 71, 391-405.
15. Lippman, S.M.; Kessler, J.F.; Meyskens, F.L. Jr. Retinoids as preventive and therapeutic anticancer agents (Part II). Cancer Treat. Rep., 1987, 71, 493-515.
16. Wald, N. Retinol, beta-carotene and cancer. Cancer Surveys, 1987, 6, 635-651.
17. Nastruzzi, C.; Simoni, D.; Manfredini, S.; Barbieri, R.; Feriotto, G.; Baraldi, P.G.; Spandidos, D.; Guarneri, M.; Gambari, R. New synthetic reinoids: effects on proliferation and differentiation. Anticancer Res., 1989, 9, 1377-1384.
18. Boone, C.W.; Kelloff, G.J.; Malone, W.E. Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review. Cancer Res., 1990, 50, 2-9.
19. Fontana J.A.; Miranda, D.; Mezu, A.B. Retinoic acid inhibition of human breast carcinoma proliferation is accompanied by the synthesis of a Mr 39,000 protein. Cancer Res., 1990, 50, 1977-1982.
20. Bertram, J. S.; Pung, A.; Churley, M.; Kappoch, T. J.; Wilkins, I. R.; Cooney, R. V. Diverse carotenoids protect against chemical induced neoplastic transformation. Carcinogenesis, 1991, 12, 671-678.
21. Ranaldi, G.; Bellovino, D.; Palozza, P.; Gaetani, S. Beneficial or detrimental effects of carotenoids contained in food: cell culture models. Mini Rev. Med. Chem., 2007, 7, 1120-1128.
22. Black H. S.; Mathews-Roth, M.M. Protective role of butylated hydroxytolune and certain carotenoids in photocarcinogenesis. Phytochem. Photobiol., 1991, 53, 707-716.
23. Zieglar, R.G. A review of epidemiologic evidence that carotinoids reduced the risk of cancer. J. Nutr., 1989, 119, 116-122.
24. Kinlen, L. J. Diet and breast cancer. Br. Med. Bull., 1991, 47, 462-469.
25. Steinmetz, K.A.; Potter, J.D.; Folsom, A.R. Vegetables, fruit and lung cancer in Iowa women's health study. Cancer Res., 1993, 53, 536-543.
26. Nair, S.C.; Panikkar, K.R. Antitumor principle from Ixora javanica. Cancer Lett, 1990, 49, 121-126.
27. Unnikrishnan, M.C.; Kuttan, R. Tumor reducing and anticarcinogenic activity of selected spices. Cancer Lett., 1990, 51, 85-89.
28. Nair, S.C.; Pannikar, B.; Panikkar, K.R. Antitumor activity of saffron (Crocus sativus). Cancer Lett., 1991, 57, 109-114.
29. Bhat, J. V.; Broker, R. Riboflavine and thiamine contents of saffron Crocus sativus. Nature, 1953, 172, 544-545.
30. Abdullaev, F. I. Espinosa-Aguirre, JJ. Biomedical properties of saffron and its potential use of cancer therapy and chemopreventive trials. Cancer Detect. Prev., 2004, 28, 426-432.
31. Chryssanthi, D.G.; Lamari, F.N.; Iatrou, G.; Pylara, A.; Karamanos, N.K.; Cordopatis, P. Inhibition of breast cancer cell proliferation by style constituents of different Crocus species. Anticancer Res., 2007, 27, 357-362.
32. Dhar, A.; Mehta, S.; Dhar, G., Dhar, K.; Banerjee, S.; Van Veldhuizen, P.; Campbell, D.R.; Banerjee, S.K. Crocetin inhibits pancreatic cancer cell proliferation and tumor progression in a xenograft mice model. Mol. Cancer Ther., 2009, 8, 315-323.
33. Giaccio, M. Crocetin from Saffron: An active component of an ancient spice. Clin. Rev. Food Sc. Nutr., 2004, 44, 155-172.
34. Sujata, V.; Ravishankar, G. A.; Venkataramn, L. V. Methods for the analysis of the saffron metabolites crocin, crocetins, picocrocin and safranal for the determination of the quality of the spice using thin layer chromatography, high performance liquid chromatography and gas chromatography. J. Chromatogr., 1992, 624, 497-502.
35. Li, N.; Lin, G.; Kwan, Y-W.; Min, Z-D. Simultaneous quantification of five major biologically active ingredients of saffron by highperformance liquid chromatography. J. Chromatogr., 1999, 849, 349-355.
36. Abdullaev, F. I. Biological effects of saffron. Biofactors 1993, 4, 83-86.
37. Alonso, G. L; Salinas M. R.; Esteban-Infantes, F. J.; Sanchez-Fernandez, M. A. Determination of safranal from saffron (Crocus sativus L.) by thermal desorption-gas chromatography. J. Agric. Food Chem., 1996, 44, 185-188.
38. Abdullaev, F. I. Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.). Exp. Biol. Med., 2002, 227, 20-25.
39. Verma, S. K.; Bordia, A. Antioxidant property of saffron in man. Ind. J. Med. Sci., 1998, 52, 205-207.
40. Abe, K.; Saito, H. Effects of saffron extract and its constituent crocin on learning behavior and long term potentiation. Phytother. Res., 2000, 14, 149-152.
41. Abe, K.; Seguira, M.; Yamaguchi, S.; Shoyama, Y.; Saito, H. Saffron extract prevents acetaldehyde-induced inhibition of long term potentiation in the rat dentate gyrus in vivo. Brain Res., 1999, 851, 287-289.
42. Zhang, Y.; Shoyama, Y.; Sugiura, M.; Saito, H. Effets of Crocus sativus L. on the ethanol-induced impairment of passive avoidance performances in mice. Biol. Pharm. Bull., 1994, 17, 217-221.
43. Sugura, M.; Shoyama, Y.; Saito, H.; Abe, K. Crocin (crocetin digentiobiose ester) prevents the inhibitory effect of ethanol on longterm potentiation in the dentate gyrus in vivo. J. Pharmcol. Exp. Ther., 1994, 271, 703-707.
44. Soeda, S.; Ochiai, T.; Paopong, L.; Tanaka, H.; Shoyama, Y.; Shimeno, H. Crocetin suppresses tumor necrosis factor-alpha-induced cell death of neuronally differentiated PC-12 cells. Life Sci., 2001, 69, 2887-2898.
45. Xuan, B.; Zhou, Y. H.; Li, N.; Min, Z. D.; Chiou, G. C. Effect of crocin analogs on ocular blood flow and retinal function. J. Ocul. Pharmacol. Ther., 1999, 15, 143-152.
46. Fatehi, M.; Rashidabady, T.; Fatehi-Hassanabad, Z. Effects of Crocus sativus petals' extract on rat blood pressure and on response induced by electrical field stimulation in the rat isolated vas deferens and guinea-pig-ileum. J. Ethnopharmacol., 2003, 84, 199-203.
47. Hosseinzadeh, H.; Younesi, H. M. Antinociceptive and antiinflammatory effects of Crocus sativus L. stigma and petal extracts in mice. BMC Pharmacol., 2002, 2, 7-15.
48. Giassi, L. J.; Poynter, A. K.; Gainer, J. L. Trans sodium crocetinate for hemorrhagic shock: effect of time delay in initiating therapy. Shock, 2002, 18, 585-588.
49. Dhar, A.; Cherian, G.; Dhar, G.; Ray, G.; Sharma, G.; Banerjee, S. K. Molecular basis of protective effect of crocetin on survival and liver tissue damage following hemorrhagic shock. Mol. Cell Biochem., 2005, 278, 139-146.
50. Mousavi, S. H, Tavakkol-Afshari, J.; Brook, A.; Jafari-Anarkooli, I. Role of capases and Bax protein in saffron-induced apoptosis in MCF-7 cells. Food Chem. Toxicol., 2009, 47, 1909-1913.
51. Abdullaev, F. I.; Frenkel, G.D. Effect of saffron on cell colony formation and cellular nucleic acid and protein synthesis. Biofactors, 1992, 3, 201-204.
52. Tavakkol-Afshari, J.; Brook, A.; Mousavi, S.H. Study of cytotoxic and apoptogenic properties of saffron extract in human cancer cell lines. Food Chem. Toxicol., 2008, 46, 3443-3447.
53. Abdullaev, F.I. Inhibitory effect of crocetin on intracellular nucleic acid and protein synthesis in malignant cells. Toxicol. Lett., 1994, 70, 243-251.
54. Escribano, J.; Alonso G. L.; Coca-Prados, M.; Fernandez, J. A. Crocin, safranal and picrocrocin from saffron (Crocus sativus L) inhibit the growth of human cancer cells in vitro. Cancer Lett., 1996, 100, 23-30.
55. Kanakis, C. D.; Tarantilis, P. A.; Tajmir-Riahi, H. A.; Polissiou, M. G. Interaction of tRNA with safranal, crocetin and dimethylcrocetin. J. Biomol. Struct. Dynam., 2007, 24, 537-545
56. Aung, H. H.; Wang, C.Z.; Ni, M.; Fishbein, A.; Mehendale, S. R.; Xie, J. T.; Shoyama, C. Y.; Yuan, C. S. Crocin from Crocus sativus possesses significant anti-proliferation effects on human colorectal cancer cells. Exp. Oncol., 2007, 29, 175-180.
57. Morjani, H.; Tarantilis, P.; Polissiou, M.; Manfeit, M. Growth inhibition and induction of inhibition of erythroid differentiation activity by crocin, dimethyl-crocetine and b-carotene on K562 cells. Anticancer Res., 1990, 10, 1398-1406.
58. Wang, C.J.; Shiah, H.S.; Lin, J. K. Modulatory effect of crocetin on aflatoxin B1 cytotoxicity and DNA adduct formation in C3H10T1/2 fibroblast cell. Cancer Lett., 1991, 56, 1-10.
59. Wang, C. J.; Shiow, S. J.; Lin, J. K. Effects of crocetin on the hepatotoxicity and hepatic DNA binding of aflatoxin B1 in rats. Carcinogenesis, 1991, 12, 459-462.
60. Wang, C. J.; Hsu, J. D.; Lin, J. K. Suppression of aflatoxin B1-induced lesions by crocetin (a natural carotenoid). Carcinogenesis, 1991, 12, 1807-1810.
61. Chang, W-C.; Lin, Y-L.; Lee, M-J.; Shiow, S-J.; Wang, C-J. Inhibitory effect of crocetin on benzo(a)pyrene genotoxicity and neoplastic transformation in C3H10T1/2 cells. Anticancer Res., 1996, 16, 3603-3608.
62. Tseng, T. H.; Chu, C.Y.; Huang, J.M.; Shiow, S.J.; Wang C.J. Crocetin protects against oxidative damage in rat primary hepatocytes. Cancer Lett., 1995, 97, 61-67.
63. Magesh, V.; Singh, J.P.; Selvendiran, K.; Ekambaram, B.; Sakthisekaran, D. Antitumor activity of crocetin in accordance to tu mor incidence, antioxidant status, drug metabolizing enzymes and histopathological studies. Mol. Cell. Biochem., 2006, 287, 127-135.
64. Magesh, V.; Durgabhavani, K.; Senthilnathan, P.; Rajendran, P.; Sakthisekaran, D. In vivo protective effect of crocetin on benzo(a)pyrene induced lung cancer in swiss albino mice. Phytother. Res., 2009, 23, 533-539.
65. Gainer, J. L.; Wallis, D. A.; Jones, J. R. The effect of skin papilloma and rous sarcoma. Oncology, 1976, 33, 222-224.
66. Ashrafi M.; Bhataie, S. Z.; Taghikhani, M.; Moosavi-Movahedi, A. A. The effect of carotenoids obtained from saffron on histone H1 structure and H1-DNA interaction. Int. J. Biol. Macromol., 2005, 36, 246-252.